Eli Lilly phase 3 studies of Emgality shows reduction in monthly migraine
Eli Lilly and Company (NYSE:...
Read MoreEli Lilly and Company (NYSE:...
Read MoreAdo-trastuzumab emtansine (Kadcyla, Genentech) has...
Read MoreTesting the blood for free...
Read MoreIntegrated healthcare platform CallHealth today...
Read MoreThe U.S. Food and Drug...
Read MoreAbbott has announced the next...
Read MoreEMA is updating the prescribing...
Read MoreAstraZeneca and BenevolentAI have begun...
Read MoreSandoz has announced that it...
Read MoreMorphoSys AG and I-Mab Biopharma...
Read More